Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

FDA to Target Addictive Levels of Nicotine in Cigarettes

By Carla K. Johnson, AP Medical Writer | July 31, 2017

In this Thursday, Nov. 10, 2016 photo, test cigarettes sit in a smoking machine in a lab at the Centers for Disease Control and Prevention in Atlanta. On Friday, July 28, 2017, the U.S. Food and Drug Administration announced that it wants to lower nicotine levels in cigarettes so they aren’t so addictive. (AP Photo/Branden Camp)

The U.S. Food and Drug Administration wants to lower nicotine levels in cigarettes so they aren’t so addictive.

FDA Commissioner Scott Gottlieb announced the move Friday. The federal agency has had the power since 2009 to cut nicotine levels but hasn’t done so. The FDA plans to seek comments as it develops new regulations.

Gottlieb also said the FDA is giving e-cigarette makers more time for a review of the products already on the market. Gottlieb said the agency needs time to focus on nicotine regulation and not be distracted by the debate on whether e-cigarettes help smokers quit.

Campaign for Tobacco-Free Kids president Matthew Myers praised the overall approach as “bold and comprehensive” but called the e-cigarettes delay “a serious error.”

Stocks of cigarette makers plunged after the announcement.


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE